Contract research firm Parexel International explores sale: Reuters

Contract drug research firm Parexel International Corp (PRXL.O) is exploring a sale, sources familiar with the matter told Reuters on Monday.

8 May 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles